痴呆症护理研究和心理社会因素
1Ontario Brain Institute, Toronto, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
对于痴呆症护理的可穿戴技术采用面临障碍. 科特克斯计划使社区能够测试和扩展神经技术,改善痴呆症诊断和护理的可访问性.
科学领域:
- 神经技术的神经技术
- 老年学是一门学科.
- 数字健康数字健康
背景情况:
- 对于具有认知障碍的老年人来说,可穿戴技术的广泛采用仍然有限.
- 这阻碍了可穿戴设备在痴呆症护理和改善结果方面的潜力.
- 采用障碍阻止利用这些技术治疗诸如轻度认知障碍 (MCI) 和阿尔茨海默病及相关痴呆症 (ADRD) 等疾病.
研究的目的:
- 分享从共同设计和启动CORTEX计划中学到的经验教训.
- 赋予社区团体和个人在测试和实施可穿戴技术方面的实践经验.
- 展示学习如何为创建加拿大痴呆症注册表提供信息.
主要方法:
- 与社区团体和有实践经验的人共同设计CORTEX计划.
- 与患者团体合作进行试点研究.
- 与安大略省阿尔茨海默病学会合作,推出加拿大痴呆症注册表.
主要成果:
- 该CORTEX计划授权社区主导的神经技术的测试和扩展.
- 试点研究为在现实环境中实施可穿戴技术提供了有价值的见解.
- 加拿大痴呆症注册表有助于理解痴呆症诊断,测试神经技术,并将其整合到护理途径中.
结论:
- 像CORTEX这样的社区主导的倡议对于克服在痴呆症护理中采用可穿戴技术的障碍至关重要.
- 共同设计和现实世界的测试提高神经技术的相关性和可扩展性.
- 加拿大痴呆症登记处是促进痴呆症研究和改善护理准入的平台.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
01:29Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:30Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K